Skip to main content

Publications

featured publications

  • Further Evidence That MicroRNAs Can Play a Role in Hemophilia A Disease Manifestation: Gene Downregulation by miR-19b-3p and miR-186-5p.

    Frontiers in cell and developmental biology

    Authors: Katarzyna I Jankowska, Joseph McGill, Behnaz Pezeshkpoor, Johannes Oldenburg, Zuben E Sauna, Chintamani D Atreya

  • Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors.

    Hamostaseologie

    Authors: Hans H Brackmann, Wolfgang Schramm, Johannes Oldenburg, Viridiana Cano, Peter L Turecek, Claude Négrier

  • Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.

    Scientific reports

    Authors: Sara Reda, Anna Brügelmann, Jens Müller, Johannes Oldenburg, Bernd Pötzsch, Heiko Rühl

  • Glycophorin A-based exclusion of red blood cells for flow cytometric analysis of platelet glycoprotein expression in citrated whole blood.

    Clinical chemistry and laboratory medicine

    Authors: Christina Berens, Johannes Oldenburg, Bernd Pötzsch, Jens Müller

  • Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A.

    Hamostaseologie

    Authors: Katharina Holstein, Manuela Albisetti, Christoph Bidlingmaier, Susan Halimeh, Sabine Heine, Robert Klamroth, Christoph Königs, Karin Kurnik, Christoph Male, Johannes Oldenburg, Werner Streif, Cornelia Wermes, Carmen Escuriola-Ettingshausen

  • High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Maria Elisa Mancuso, Johannes Oldenburg, Lisa Boggio, Gili Kenet, Anthony Chan, Carmen Altisent, Wilfried Seifert, Elena Santagostino

  • Long-term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B-YOND extension study.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: K John Pasi, Kathelijn Fischer, Margaret Ragni, Roshni Kulkarni, Margareth C Ozelo, Johnny Mahlangu, Amy Shapiro, Stephanie P'Ng, Hervé Chambost, Beatrice Nolan, Carolyn Bennett, Tadashi Matsushita, Bent Winding, Joachim Fruebis, Huixing Yuan, Dan Rudin, Johannes Oldenburg

  • Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.

    Hamostaseologie

    Authors: Florian Langer, Stefan Kluge, Robert Klamroth, Johannes Oldenburg

  • Selective Modulation of the Protease Activated Protein C Using Exosite Inhibiting Aptamers.

    Nucleic acid therapeutics

    Authors: Nasim Shahidi Hamedani, Jens Müller, Fabian Tolle, Heiko Rühl, Behnaz Pezeshkpoor, Kerstin Liphardt, Johannes Oldenburg, Günter Mayer, Bernd Pötzsch

  • octanate: over 20 years of clinical experience in overcoming challenges in haemophilia A treatment.

    Therapeutic advances in hematology

    Authors: Anna Klukowska, Vladimír Komrska, Vladimír Vdovin, Nadezhda Zozulya, Toshko Lissitchkov, Johannes Oldenburg, Carmen Escuriola Ettingshausen